Natco Pharma Ltd.

BSE: 524816 | NSE: NATCOPHARM
Small Cap | Pharmaceuticals & Drugs
923.65
5.75 (0.63%)
< Home < Back

Natco Pharma - Quaterly Results

Date: 14-02-2024
The turnover zoomed to Rs. 6253.00 millions, up 51.40% for the December 2023 quarter as against Rs. 4130.00 millions during the year-ago period.The Net Profit of the company reported a remarkable increase of 414.75% to Rs. 1920.00  millions  from Rs. 373.00 millions in previous same quarter.The company reported a good operating profit of 2678.00 millions compared to 861.00 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 6253.00 4130.00 51.40 26041.00 15698.00 65.89 23510.00 17678.00 32.99
Other Income 295.00 186.00 58.60 688.00 680.00 1.18 855.00 946.00 -9.62
PBIDT 2678.00 861.00 211.03 12531.00 5850.00 114.21 9302.00 3076.00 202.41
Interest 38.00 30.00 26.67 100.00 74.00 35.14 86.00 133.00 -35.34
PBDT 2640.00 831.00 217.69 12431.00 5776.00 115.22 9216.00 2943.00 213.15
Depreciation 404.00 381.00 6.04 1203.00 1133.00 6.18 1509.00 1384.00 9.03
PBT 2236.00 450.00 396.89 11228.00 4643.00 141.83 7707.00 1559.00 394.36
TAX 316.00 77.00 310.39 1653.00 813.00 103.32 1336.00 168.00 695.24
Deferred Tax -105.00 -3.00 3400.00 -359.00 -19.00 1789.47 5.00 -157.00 -103.18
PAT 1920.00 373.00 414.75 9575.00 3830.00 150.00 6371.00 1391.00 358.02
Equity 358.00 365.00 -1.92 358.00 365.00 -1.92 365.00 365.00 0.00
PBIDTM(%) 42.83 20.85 105.43 48.12 37.27 29.13 39.57 17.40 127.39